Invesco Ltd. Vertex Pharmaceuticals Inc Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,802,742 shares of VRTX stock, worth $838 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,802,742

Previous 2,091,143 13.79%

Holding current value

$838 Million

Previous $874 Million 3.33%

% of portfolio

0.18%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $113 Million - $140 Million	-288,401 Reduced 13.79%	1,802,742 $845 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $61.5 Million - $67.3 Million	-150,964 Reduced 6.73%	2,091,143 $874 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $77.3 Million - $92.5 Million	225,327 Added 11.17%	2,242,107 $912 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $22.8 Million - $24.4 Million	67,451 Added 3.46%	2,016,780 $701 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $27.7 Million - $31 Million	87,961 Added 4.73%	1,949,329 $686 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $67 Million - $76.4 Million	236,469 Added 14.55%	1,861,368 $586 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $87.2 Million - $98.1 Million	305,217 Added 23.13%	1,624,899 $469 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $53.9 Million - $60.2 Million	196,888 Added 17.54%	1,319,682 $382 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $20.6 Million - $25.6 Million	-87,563 Reduced 7.23%	1,122,794 $316 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $19.5 Million - $23 Million	88,199 Added 7.86%	1,210,357 $316 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $16.3 Million - $20.6 Million	-92,335 Reduced 7.6%	1,122,158 $246 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $8.78 Million - $9.83 Million	48,410 Added 4.15%	1,214,493 $220 Million
Q2 2021 Aug 17, 2021	BUY	$187.49 - $221.1 $37 Million - $43.7 Million	197,494 Added 20.39%	1,166,083 $235 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $26.8 Million - $31.2 Million	-129,332 Reduced 11.78%	968,589 $208 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $6.84 Million - $9.12 Million	-33,046 Reduced 2.92%	1,097,921 $259 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $2.88 Million - $3.41 Million	11,258 Added 1.01%	1,130,967 $308 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $41 Million - $53.8 Million	-182,032 Reduced 13.98%	1,119,709 $325 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $41.4 Million - $51.4 Million	207,470 Added 18.96%	1,301,741 $310 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $428 Million - $574 Million	-2,565,660 Reduced 70.1%	1,094,271 $240 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $67.2 Million - $75.6 Million	-403,977 Reduced 9.94%	3,659,931 $620 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $55.3 Million - $64 Million	335,938 Added 9.01%	4,063,908 $745 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $3.56 Million - $4.24 Million	21,753 Added 0.59%	3,727,970 $686 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $563 Million - $712 Million	3,706,217 New	3,706,217 $614 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account